These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29806769)
1. The use of drug-coated balloons in the treatment of femoropopliteal and infrapopliteal disease. Li J; Karim A; Shishehbor MH J Cardiovasc Surg (Torino); 2018 Aug; 59(4):512-525. PubMed ID: 29806769 [TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Restenosis after Drug-coated Balloon Angioplasty for Complex Femoropopliteal Arterial Occlusive Disease. Roh JW; Ko YG; Ahn CM; Hong SJ; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y Ann Vasc Surg; 2019 Feb; 55():45-54. PubMed ID: 30118857 [TBL] [Abstract][Full Text] [Related]
4. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease. Werner M Vasa; 2016 Sep; 45(5):365-72. PubMed ID: 27351416 [TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582 [TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854 [TBL] [Abstract][Full Text] [Related]
7. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry. Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial. Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; Sixt S; Brucks S; Beschorner U; Klumb CT; Thieme M; EuroIntervention; 2020 Apr; 15(18):e1633-e1640. PubMed ID: 31687933 [TBL] [Abstract][Full Text] [Related]
9. Device Selection in Femoral-Popliteal Arterial Interventions. Kim SM; Kim LK; Feldman DN Interv Cardiol Clin; 2020 Apr; 9(2):197-206. PubMed ID: 32147120 [TBL] [Abstract][Full Text] [Related]
15. The use of scoring balloons in the superficial femoral artery. Bays S J Cardiovasc Surg (Torino); 2018 Aug; 59(4):504-511. PubMed ID: 29786412 [TBL] [Abstract][Full Text] [Related]
16. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972 [TBL] [Abstract][Full Text] [Related]
17. Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line? Sattar Y; Aronow HD; Alam M J Am Coll Cardiol; 2022 Sep; 80(13):1251-1253. PubMed ID: 36137675 [No Abstract] [Full Text] [Related]
18. The evolving role of drug-coated balloons for the treatment of complex femoropopliteal lesions. Korosoglou G; Lichtenberg M; Celik S; Andrassy J; Brodmann M; Andrassy M J Cardiovasc Surg (Torino); 2018 Feb; 59(1):51-59. PubMed ID: 28975777 [TBL] [Abstract][Full Text] [Related]